BCRX

#1599
BioCryst Pharmaceuticals, Inc. - Common Stock
8.9 1 USD
-1.87%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
8.91
8.91
年范围
6.00
11.31
日变化
-1.87%
每月变动
-1.11%
6个月变化
+25.85%
年变化
-17.88%
前一天收盘价
9.0 8
Open
8.9 1
最低价
8.9 1
High
8.9 1
交易量
277
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
利润表 资产负债表 现金流
值 202020212022202320242025 TTM

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

新闻